(Total Views: 472)
Posted On: 03/07/2021 1:42:21 PM
Post# of 148928
Re: reallypeople? #81616
Not all shareholders created equal.
_________________
"Everyone’s expectations on Cytodyn the trials and the the drug were always way to high . And NP never tampers those expectations . Even promotes them . This is a problem for all shareholders ."
Read More: https://investorshangout.com/post/view?id=607...z6oS5uevfL
__________________
On the contrary, the problem, and a big one, is that the thoughtless pumping of this stock here is a problem only for the latecomers who have paid X-dollars per share and who presently constitute a huge majority of shareholders. So the CYDY pumping benefits only the core group that entered the stock at X-cents.
From what I read on this board, quite a few of them will be selling on Monday and buying the bottom. They can well afford this. This will crush the latecomers who cannot afford flipping since they are already below the cost or about even.
_________________
"Everyone’s expectations on Cytodyn the trials and the the drug were always way to high . And NP never tampers those expectations . Even promotes them . This is a problem for all shareholders ."
Read More: https://investorshangout.com/post/view?id=607...z6oS5uevfL
__________________
On the contrary, the problem, and a big one, is that the thoughtless pumping of this stock here is a problem only for the latecomers who have paid X-dollars per share and who presently constitute a huge majority of shareholders. So the CYDY pumping benefits only the core group that entered the stock at X-cents.
From what I read on this board, quite a few of them will be selling on Monday and buying the bottom. They can well afford this. This will crush the latecomers who cannot afford flipping since they are already below the cost or about even.
(1)
(0)
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.
Scroll down for more posts ▼
